Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review.
The company will continue to invest in clinical research and expand its team to grow partnerships with employers and health plans.
Kaia Health’s smartphone-based platform combines machine learning and the expertise of medical experts to create individualized treatments, including exercises, education and psychological interventions for patients. Since launching in 2016, Kaia Health has enrolled more than 400,000 users and raised $50 million.
More articles on digital transformation:
Texas Children’s is building a ‘startup culture’ with innovation, tech at the forefront
Four health tech companies expected to reach $1B soon
Optum Ventures leads funding for patient engagement platform: 4 details
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
